+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Postmenopausal Osteoporosis Treatment Market Size, Share & Trends Analysis Report By Drug Type (Bisphosphonates, Vitamin D3), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies), And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 180 Pages
  • May 2023
  • Region: Global
  • Grand View Research
  • ID: 5830904
Description Jump to:
The global postmenopausal osteoporosis treatment market size is expected to reach USD 13.7 billion by 2030 and is expected to expand at a CAGR of 5.22% from 2023 to 2030. The market has grown significantly as a result of the growing geriatric population and lifestyle changes. As the older population is more susceptible, their population growth is anticipated to be a major driving force behind the market expansion. For instance, the number of people aged 60 years and above is predicted to rise from 1 billion in 2020 to 1.4 billion by 2030 and 2.1 billion by 2050, according to the World Health Organization's October 2021 report. As a result, the market is anticipated to expand during the forecast period due to a rise in demand for postmenopausal osteoporosis treatment among older people.

In addition, lifestyle modifications like inactivity, excessive alcohol consumption, smoking, long work hours, and uealthy eating patterns have an impact on menopause and increase the risk of osteoporosis in many women around the globe. Furthermore, age, smoking, alcohol consumption, and the use of drugs to address illnesses like gonadotropins, excessive thyroid hormone use, & cytotoxic agents are a few of the risk factors that can lead to low bone density and the development of the condition in women after menopause. Thus, it will drive the market growth. In 2021, more than 200 million women were affected with osteoporosis, and 1 in 3 women over 50 years of age are predicted to sustain an osteoporosis fracture, according to statistics from the International Menopause Society (IMS). As a result of the aforementioned factors, it is anticipated that the studied market will expand over the projected period.

However, it is anticipated that during the projection era, low awareness about the disease will impede industry growth. In the forecast period, there will likely be a significant increase in research and development efforts as a result of investments made by industry participants and research institutions. For instance, according to the information posted on clinicaltrial.gov, as of June 2021, there were approximately 25 ongoing phase III as well as phase IV clinical trials for osteoporosis medications in the U.S. Consequently, as a result of the aforementioned factors, the market is expected to grow over the forecast period. For instance, Eli Lilly and Company is creating blosozumab, a humanized IgG4 monoclonal antibody, to treat postmenopausal osteoporosis. It is an inhibitor of the SOST protein and is presently undergoing phase II clinical studies.

Postmenopausal Osteoporosis Treatment Market Report Highlights

  • By drug class, the bisphosphonate segment accounted for the largest share in 2022
  • Bisphosphonates have several benefits, including the ability to stop bone thinning, increase bone strength, preserve bone structure, and lower the chance of fracture in people with osteoporosis
  • By distribution channel, the hospital pharmacy segment accounted for the largest share in 2022. The market is expanding as a result of the high hospitalization rate associated with the target disease
  • North America held the largest share in 2022 due to the strong presence of key market participants, as well as rising R&D spending and federal assistance, in the region
  • Asia Pacific is expected to grow at the highest CAGR over the projected period due to the rising prevalence of target disease, the growing aging population, and the increasing adoption of postmenopausal osteoporosis treatments


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Research Methodology
1.1 Market Segmentation & Scope
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity flow approach
1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
1.7 Global Market: CAGR Calculation
1.8 Research Assumptions
1.9 List of Secondary Sources
1.10 List of Primary Sources
1.11 Objectives
1.11.1 Objective 1:
1.11.2 Objective 2:
1.12 List Of Abbreviations
Chapter 2 Market Definitions
Chapter 3 Executive Summary
3.1 Market Summary
Chapter 4 Global Postmenopausal Osteoporosis Treatment Market Variables, Trends, & Scope
4.1 Postmenopausal Osteoporosis Treatment Market Lineage Outlook
4.1.1 Parent Market Outlook
4.2 Penetration And Growth Prospect Mapping
4.3 Regulatory Framework
4.4 Market Driver Analysis
4.4.1 Increase In Geriatric Population
4.4.2 Rising Prevalence Of Osteoporosis
4.5 Market Restraint Analysis
4.5.1 Low Awarenss About Postmenopause Osteoporosis
4.6 Porter’s Five Forces Analysis
4.7 Swot Analysis
4.8 Covid-19 Impact Analysis
Chapter 5 Postmenopausal Osteoporosis Treatment Market - Segment Analysis, By Drug Type , 2018 - 2030 (USD Million)
5.1 Global Postmenopausal Osteoporosis Treatment Market: Drug Type Movement Analysis
5.2 Bisphosphonates
5.2.1 Bisphosphonates Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.3 Vitamin D3
5.3.1 Vitamin D3 Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.4 Estrogen Agonist/Antagonist
5.4.1 Estrogen Agonist/Antagonist Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.5 Hormone Replacement Therapy
5.5.1 Hormone Replacement Therapy Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.6 Parathyroid Hormone Therapy
5.5.1 Parathyroid Hormone Therapy Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.7 Others
5.5.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 6 Postmenopausal osteoporosis treatment market - Segment Analysis, by Distribution Channel, 2018 - 2030 (USD Million)
6.1 Global Postmenopausal osteoporosis treatment market: Distribution Channel Movement Analysis
6.2 Hospital Pharmacies
6.2.1 Hospital Pharmacies Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3 Retail Pharmacies
6.3.1 Retail Pharmacies Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4 Others
6.4.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 9 Postmenopausal Osteoporosis Treatment Market: - Segment Analysis, By Region, 2018 - 2030 (USD Million)
9.1 Postmenopausal Osteoporosis Treatment Market: Regional Movement Analysis
9.2 North America
9.2.1 Swot Analysis
9.2.1.1 North America Postmenopausal Osteoporosis Treatment Market, 2018 - 2030 (USD Million)
9.2.2 U.S.
9.2.2.1 Key country dynamics
9.2.2.2 Competitive scenario
9.2.2.3 U.S. Postmenopausal osteoporosis treatment market, 2018 - 2030 (USD Million)
9.2.3 Canada
9.2.3.1 Key country dynamics
9.2.3.2 Competitive scenario
9.2.3.3 Canada Postmenopausal osteoporosis treatment market, 2018 - 2030 (USD Million)
9.3 Europe
9.3.1 Swot Analysis
9.3.1.1 Europe Postmenopausal osteoporosis treatment market estimates and forecast, 2018 - 2030 (USD Million)
9.3.2 Germany
9.3.2.1 Key country dynamics
9.3.2.2 Competitive scenario
9.3.2.3 Germany Postmenopausal osteoporosis treatment market, 2018 - 2030 (USD Million)
9.3.3 France
9.3.3.1 Key country dynamics
9.3.3.2 Competitive scenario
9.3.3.3 France Postmenopausal osteoporosis treatment market, 2018 - 2030 (USD Million)
9.3.4 UK
9.3.4.1 Key country dynamics
9.3.4.2 Competitive scenario
9.3.4.3 UK Postmenopausal osteoporosis treatment market, 2018 - 2030 (USD Million)
9.3.5 Italy
9.3.5.1 Key country dynamics
9.3.5.2 Competitive scenario
9.3.5.3 Italy Postmenopausal osteoporosis treatment market, 2018 - 2030 (USD Million)
9.3.6 Spain
9.3.6.1 Key country dynamics
9.3.6.2 Competitive scenario
9.3.6.3 Spain Postmenopausal osteoporosis treatment market, 2018 - 2030 (USD Million)
9.3.7 Denmark
9.3.7.1 Key country dynamics
9.3.7.2 Competitive scenario
9.3.7.3 Denmark Postmenopausal osteoporosis treatment market, 2018 - 2030 (USD Million)
9.3.8 Sweden
9.3.8.1 Key country dynamics
9.3.8.2 Competitive scenario
9.3.8.3 Sweden Postmenopausal osteoporosis treatment market, 2018 - 2030 (USD Million)
9.3.9 Norway
9.3.9.1 Key country dynamics
9.3.9.2 Competitive scenario
9.3.9.3 Norway Postmenopausal osteoporosis treatment market, 2018 - 2030 (USD Million)
9.4 Asia Pacific
9.4.1 Swot Analysis
9.4.1.1 Asia Pacific Postmenopausal osteoporosis treatment, 2018 - 2030 (USD Million)
9.4.2 Japan
9.4.2.1 Key country dynamics
9.4.2.2 Competitive scenario
9.4.2.3 Japan Postmenopausal osteoporosis treatment market, 2018 - 2030 (USD Million)
9.4.3 China
9.4.3.1 Key country dynamics
9.4.3.2 Competitive scenario
9.4.3.3 China Postmenopausal osteoporosis treatment market, 2018 - 2030 (USD Million)
9.4.4 India
9.4.4.1 Key country dynamics
9.4.4.2 Competitive scenario
9.4.4.3 India Postmenopausal osteoporosis treatment market, 2018 - 2030 (USD Million)
9.4.5 Australia
9.4.5.1 Key country dynamics
9.4.5.2 Competitive scenario
9.4.5.3 Australia Postmenopausal osteoporosis treatment market, 2018 - 2030 (USD Million)
9.4.6 South Korea
9.4.6.1 Key country dynamics
9.4.6.2 Competitive scenario
9.4.6.3 South Korea Postmenopausal osteoporosis treatment market, 2018 - 2030 (USD Million)
9.4.7 Thailand
9.4.7.1 Key country dynamics
9.4.7.2 Competitive scenario
9.4.7.3 Thailand Postmenopausal osteoporosis treatment market, 2018 - 2030 (USD Million)
9.5 Latin America
9.5.1 Swot Analysis
9.5.1.1 Latin America Postmenopausal osteoporosis treatment market, 2018 - 2030 (USD Million)
9.5.2 Brazil
9.5.2.1 Key country dynamics
9.5.2.2 Competitive scenario
9.5.2.3 Brazil Postmenopausal osteoporosis treatment market, 2018 - 2030 (USD Million)
9.5.3 Mexico
9.5.3.1 Key country dynamics
9.5.3.2 Competitive scenario
9.5.3.3 Mexico Postmenopausal osteoporosis treatment market, 2018 - 2030 (USD Million)
9.5.4 Argentina
9.5.4.1 Key country dynamics
9.5.4.2 Competitive scenario
9.5.4.3 Argentina Postmenopausal osteoporosis treatment market, 2018 - 2030 (USD Million)
9.6 Middle East & Africa (MEA)
9.6.1 Swot Analysis
9.6.1.1 MEA Postmenopausal osteoporosis treatment market estimates and forecast, 2018 - 2030 (USD Million)
9.6.2 South Africa
9.6.2.1 Key country dynamics
9.6.2.2 Competitive scenario
9.6.2.3 South Africa Postmenopausal osteoporosis treatment market estimates and forecast, 2018 - 2030 (USD Million)
9.6.3 Saudi Arabia
9.6.3.1 Key country dynamics
9.6.3.2 Competitive scenario
9.6.3.3 Saudi Arabia Postmenopausal osteoporosis treatment market estimates and forecast, 2018 - 2030 (USD Million)
9.6.4 UAE
9.6.4.1 Key country dynamics
9.6.4.2 Competitive scenario
9.6.4.3 UAE Postmenopausal osteoporosis treatment market estimates and forecast, 2018 - 2030 (USD Million)
9.6.5 Kuwait
9.6.5.1 Key country dynamics
9.6.5.2 Competitive scenario
9.6.5.3 Kuwait Postmenopausal osteoporosis treatment market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 10 Competitive Landscape
10.1 Participant’s overview
10.1.1 Teva Pharmaceuticals Industries Ltd.
10.1.1.1 Company overview
10.1.1.2 Financial performance
10.1.1.3 Product benchmarking
10.1.1.4 Strategic Initiatives
10.1.2 Pfizer Inc.
10.1.2.1 Company overview
10.1.2.2 Financial performance
10.1.2.3 Product benchmarking
10.1.2.4 Strategic Initiatives
10.1.3 Merck & Co.
10.1.3.1 Company overview
10.1.3.2 Financial performance
10.1.3.3 Product benchmarking
10.1.3.4 Strategic Initiatives
10.1.4 Novartis AG
10.1.4.1 Company overview
10.1.4.2 Financial performance
10.1.4.3 Product benchmarking
10.1.4.4 Strategic Initiatives
10.1.5 Eli Lilly and Company
10.1.5.1 Company overview
10.1.5.2 Financial performance
10.1.5.3 Product benchmarking
10.1.5.4 Strategic Initiatives
10.1.6 AbbVie (Allergan plc.)
10.1.6.1 Company overview
10.1.6.2 Financial performance
10.1.6.3 Product benchmarking
10.1.6.4 Strategic Initiatives
10.1.7 F. Hoffmann-La Roche Ltd.
10.1.7.1 Company overview
10.1.7.2 Financial performance
10.1.7.3 Product benchmarking
10.1.7.4 Strategic initiatives
10.1.8 Cipla Inc.
10.1.8.1 Company overview
10.1.8.2 Financial performance
10.1.8.3 Product benchmarking
10.1.8.4 Strategic initiatives
10.1.9 Amgen Inc.
10.1.9.1 Company overview
10.1.9.2 Financial performance
10.1.9.3 Product benchmarking
10.1.9.4 Strategic initiatives
10.2 Participant categorization
10.3 Postmenopausal osteoporosis treatment market share analysis, 2022
10.4 Strategy mapping
10.4.1 Expansion
10.4.2 Acquisition
10.4.3 Collaborations
10.4.4 Product/service launch
10.4.5 Partnerships
10.4.6 Others
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global Postmenopausal osteoporosis treatment market by Drug Type , 2018 - 2030 (USD Million)
Table 4 Global Postmenopausal osteoporosis treatment market by Distribution Channel, 2018 - 2030 (USD Million)
Table 5 North America Postmenopausal osteoporosis treatment market by Drug Type , 2018 - 2030 (USD Million)
Table 6 North America Postmenopausal osteoporosis treatment market by Distribution Channel, 2018 - 2030 (USD Million)
Table 7 North America Postmenopausal osteoporosis treatment market by Country, 2018 - 2030 (USD Million)
Table 8 U.S. Postmenopausal osteoporosis treatment market by Drug Type , 2018 - 2030 (USD Million)
Table 9 U.S. Postmenopausal osteoporosis treatment market by Distribution Channel, 2018 - 2030 (USD Million)
Table 10 Canada Postmenopausal osteoporosis treatment market by Drug Type , 2018 - 2030 (USD Million)
Table 11 Canada Postmenopausal osteoporosis treatment market by Distribution Channel, 2018 - 2030 (USD Million)
Table 12 Europe Postmenopausal osteoporosis treatment market by Drug Type , 2018 - 2030 (USD Million)
Table 13 Europe Postmenopausal osteoporosis treatment market by Distribution Channel, 2018 - 2030 (USD Million)
Table 14 Europe Postmenopausal osteoporosis treatment market by Country, 2018 - 2030 (USD Million)
Table 15 UK Postmenopausal osteoporosis treatment market by Drug Type , 2018 - 2030 (USD Million)
Table 16 UK Postmenopausal osteoporosis treatment market by Distribution Channel, 2018 - 2030 (USD Million)
Table 17 Germany Postmenopausal osteoporosis treatment market by Drug Type , 2018 - 2030 (USD Million)
Table 18 Germany Postmenopausal osteoporosis treatment market by Distribution Channel, 2018 - 2030 (USD Million)
Table 19 France Postmenopausal osteoporosis treatment market by Drug Type , 2018 - 2030 (USD Million)
Table 20 France Postmenopausal osteoporosis treatment market by Distribution Channel, 2018 - 2030 (USD Million)
Table 21 Italy Postmenopausal osteoporosis treatment market by Drug Type , 2018 - 2030 (USD Million)
Table 22 Italy Postmenopausal osteoporosis treatment market by Distribution Channel, 2018 - 2030 (USD Million)
Table 23 Spain Postmenopausal osteoporosis treatment market by Drug Type , 2018 - 2030 (USD Million)
Table 24 Spain Postmenopausal osteoporosis treatment market by Distribution Channel, 2018 - 2030 (USD Million)
Table 25 Denmark Postmenopausal osteoporosis treatment market by Drug Type , 2018 - 2030 (USD Million)
Table 26 Denmark Postmenopausal osteoporosis treatment market by Distribution Channel, 2018 - 2030 (USD Million)
Table 27 Sweden Postmenopausal osteoporosis treatment market by Drug Type , 2018 - 2030 (USD Million)
Table 28 Sweden Postmenopausal osteoporosis treatment market by Distribution Channel, 2018 - 2030 (USD Million)
Table 29 Norway Postmenopausal osteoporosis treatment market by Drug Type , 2018 - 2030 (USD Million)
Table 30 Norway Postmenopausal osteoporosis treatment market by Distribution Channel, 2018 - 2030 (USD Million)
Table 31 Asia Pacific Postmenopausal osteoporosis treatment market by Drug Type , 2018 - 2030 (USD Million)
Table 32 Asia Pacific Postmenopausal osteoporosis treatment market by Distribution Channel, 2018 - 2030 (USD Million)
Table 33 Asia Pacific Postmenopausal osteoporosis treatment market by Country, 2018 - 2030 (USD Million)
Table 34 China Postmenopausal osteoporosis treatment market by Drug Type , 2018 - 2030 (USD Million)
Table 35 China Postmenopausal osteoporosis treatment market by Distribution Channel, 2018 - 2030 (USD Million)
Table 36 Japan Postmenopausal osteoporosis treatment market by Drug Type , 2018 - 2030 (USD Million)
Table 37 Japan Postmenopausal osteoporosis treatment market by Distribution Channel, 2018 - 2030 (USD Million)
Table 38 India Postmenopausal osteoporosis treatment market by Drug Type , 2018 - 2030 (USD Million)
Table 39 India Postmenopausal osteoporosis treatment market by Distribution Channel, 2018 - 2030 (USD Million)
Table 40 Australia Postmenopausal osteoporosis treatment market by Drug Type , 2018 - 2030 (USD Million)
Table 41 Australia Postmenopausal osteoporosis treatment market by Distribution Channel, 2018 - 2030 (USD Million)
Table 42 Australia Postmenopausal osteoporosis treatment market by Application, 2018 - 2030 (USD Million)
Table 43 Thailand Postmenopausal osteoporosis treatment market by Distribution Channel, 2018 - 2030 (USD Million)
Table 44 South Korea Postmenopausal osteoporosis treatment market by Drug Type , 2018 - 2030 (USD Million)
Table 45 South Korea Postmenopausal osteoporosis treatment market by Distribution Channel, 2018 - 2030 (USD Million)
Table 46 Latin America Postmenopausal osteoporosis treatment market by Drug Type , 2018 - 2030 (USD Million)
Table 47 Latin America Postmenopausal osteoporosis treatment market by Distribution Channel, 2018 - 2030 (USD Million)
Table 48 Latin America Postmenopausal osteoporosis treatment market by Country, 2018 - 2030 (USD Million)
Table 49 Brazil Postmenopausal osteoporosis treatment market by Drug Type , 2018 - 2030 (USD Million)
Table 50 Brazil Postmenopausal osteoporosis treatment market by Distribution Channel, 2018 - 2030 (USD Million)
Table 51 Mexico Postmenopausal osteoporosis treatment market by Drug Type , 2018 - 2030 (USD Million)
Table 52 Mexico Postmenopausal osteoporosis treatment market by Distribution Channel, 2018 - 2030 (USD Million)
Table 53 Argentina Postmenopausal osteoporosis treatment market by Drug Type , 2018 - 2030 (USD Million)
Table 54 Argentina Postmenopausal osteoporosis treatment market by Distribution Channel, 2018 - 2030 (USD Million)
Table 55 Middle East & Africa Postmenopausal osteoporosis treatment market by Drug Type , 2018 - 2030 (USD Million)
Table 56 Middle East & Africa Postmenopausal osteoporosis treatment market by Distribution Channel, 2018 - 2030 (USD Million)
Table 57 Middle East & Africa Postmenopausal osteoporosis treatment market by Country, 2018 - 2030 (USD Million)
Table 58 South Africa Postmenopausal osteoporosis treatment market by Drug Type , 2018 - 2030 (USD Million)
Table 59 South Africa Postmenopausal osteoporosis treatment market by Distribution Channel, 2018 - 2030 (USD Million)
Table 60 Saudi Arabia Postmenopausal osteoporosis treatment market by Drug Type , 2018 - 2030 (USD Million)
Table 61 Saudi Arabia Postmenopausal osteoporosis treatment market by Distribution Channel, 2018 - 2030 (USD Million)
Table 62 UAE Postmenopausal osteoporosis treatment market by Drug Type , 2018 - 2030 (USD Million)
Table 63 UAE Postmenopausal osteoporosis treatment market by Distribution Channel, 2018 - 2030 (USD Million)
Table 64 Kuwait Postmenopausal osteoporosis treatment market by Drug Type , 2018 - 2030 (USD Million)
Table 65 Kuwait Postmenopausal osteoporosis treatment market by Distribution Channel, 2018 - 2030 (USD Million)
Table 66 Participant’s overview
Table 67 Financial performance
Table 68 Key companies undergoing expansions
Table 69 Key companies undergoing acquisitions
Table 70 Key companies undergoing collaborations
Table 71 Key companies launching new products/services
Table 72 Key companies undergoing partnerships
Table 73 Key companies undertaking other strategies
List of Figures
Figure 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value-chain-based sizing & forecasting
Figure 6 QFD modeling for market share assessment
Figure 7 Market formulation & validation
Figure 8 Market summary, 2022 (USD Million)
Figure 9 Market segmentation & scope
Figure 10 Market driver impact
Figure 11 Market restraint impact
Figure 12 Penetration & growth prospect mapping
Figure 13 Porter’s analysis
Figure 14 SWOT analysis
Figure 15 Postmenopausal osteoporosis treatment market: Drug type outlook and key takeaways
Figure 16 Postmenopausal osteoporosis treatment market: Drug type movement analysis
Figure 17 Global Bisphosphonates market, 2018 - 2030 (USD Million)
Figure 18 Global Vitamin D3 market, 2018 - 2030 (USD Million)
Figure 19 Global Estrogen agonist/antagonist market, 2018 - 2030 (USD Million)
Figure 20 Global fixed films market, 2018 - 2030 (USD Million)
Figure 21 Global Hormone replacement therapy market, 2018 - 2030 (USD Million)
Figure 22 Global Parathyroid hormone therapy market, 2018 - 2030 (USD Million)
Figure 23 Global Others market, 2018 - 2030 (USD Million)
Figure 24 Postmenopausal osteoporosis treatment market: Distribution channel outlook and key takeaways
Figure 25 Postmenopausal osteoporosis treatment market: Distribution channel movement analysis
Figure 26 Global Hospital pharmacies market, 2018 - 2030 (USD Million)
Figure 27 Global Retail pharmacies market, 2018 - 2030 (USD Million)
Figure 28 Global Others market, 2018 - 2030 (USD Million)
Figure 29 Postmenopausal osteoporosis treatment market: Regional outlook and key takeaways
Figure 30 North America: SWOT Analysis
Figure 31 North America Postmenopausal osteoporosis treatment market, 2018 - 2030 (USD Million)
Figure 32 U.S. key country dynamics
Figure 33 U.S. Postmenopausal osteoporosis treatment market, 2018 - 2030 (USD Million)
Figure 34 Canada key country dynamics
Figure 35 Canada Postmenopausal osteoporosis treatment market, 2018 - 2030 (USD Million)
Figure 36 Europe: SWOT Analysis
Figure 37 Europe Postmenopausal osteoporosis treatment market estimates and forecast, 2018 - 2030 (USD Million)
Figure 38 Germany key country dynamics
Figure 39 Germany Postmenopausal osteoporosis treatment market estimates and forecast, 2018 - 2030 (USD Million)
Figure 40 France key country dynamics
Figure 41 France Postmenopausal osteoporosis treatment market estimates and forecast, 2018 - 2030 (USD Million)
Figure 42 UK key country dynamics
Figure 43 UK Postmenopausal osteoporosis treatment market estimates and forecast, 2018 - 2030 (USD Million)
Figure 44 Italy key country dynamics
Figure 45 Italy Postmenopausal osteoporosis treatment market estimates and forecast, 2018 - 2030 (USD Million)
Figure 46 Spain key country dynamics
Figure 47 Spain Postmenopausal osteoporosis treatment market estimates and forecast, 2018 - 2030 (USD Million)
Figure 48 Denmark key country dynamics
Figure 49 Denmark Postmenopausal osteoporosis treatment market estimates and forecast, 2018 - 2030 (USD Million)
Figure 50 Sweden key country dynamics
Figure 51 Sweden Postmenopausal osteoporosis treatment market estimates and forecast, 2018 - 2030 (USD Million)
Figure 52 Norway key country dynamics
Figure 53 Norway Postmenopausal osteoporosis treatment market estimates and forecast, 2018 - 2030 (USD Million)
Figure 54 Rest of Europe key country dynamics
Figure 55 Rest of Europe Postmenopausal osteoporosis treatment market estimates and forecast, 2018 - 2030 (USD Million)
Figure 56 Asia-Pacific: SWOT Analysis
Figure 57 Asia-Pacific Postmenopausal osteoporosis treatment market estimates and forecast, 2018 - 2030 (USD Million)
Figure 58 China key country dynamics
Figure 59 China Postmenopausal osteoporosis treatment market estimates and forecast, 2018 - 2030 (USD Million)
Figure 60 India key country dynamics
Figure 61 India Postmenopausal osteoporosis treatment market estimates and forecast, 2018 - 2030 (USD Million)
Figure 62 South Korea key country dynamics
Figure 63 South Korea Postmenopausal osteoporosis treatment market estimates and forecast, 2018 - 2030 (USD Million)
Figure 64 Japan key country dynamics
Figure 65 Japan Postmenopausal osteoporosis treatment market estimates and forecast, 2018 - 2030 (USD Million)
Figure 66 Australia key country dynamics
Figure 67 Australia Postmenopausal osteoporosis treatment market estimates and forecast, 2018 - 2030 (USD Million)
Figure 68 Thailand key country dynamics
Figure 69 Thailand Postmenopausal osteoporosis treatment market estimates and forecast, 2018 - 2030 (USD Million)
Figure 70 Rest of APAC key country dynamics
Figure 71 Rest of APAC Postmenopausal osteoporosis treatment market estimates and forecast, 2018 - 2030 (USD Million)
Figure 72 Latin America: SWOT Analysis
Figure 73 Latin America Postmenopausal osteoporosis treatment market estimates and forecast, 2018 - 2030 (USD Million)
Figure 74 Brazil key country dynamics
Figure 75 Brazil Postmenopausal osteoporosis treatment market estimates and forecast, 2018 - 2030 (USD Million)
Figure 76 Mexico key country dynamics
Figure 77 Mexico Postmenopausal osteoporosis treatment market estimates and forecast, 2018 - 2030 (USD Million)
Figure 78 Argentina key country dynamics
Figure 79 Argentina Postmenopausal osteoporosis treatment market estimates and forecast, 2018 - 2030 (USD Million)
Figure 80 Rest of LATAM key country dynamics
Figure 81 Rest of LATAM Postmenopausal osteoporosis treatment market estimates and forecast, 2018 - 2030 (USD Million)
Figure 82 MEA: SWOT Analysis
Figure 83 MEA Postmenopausal osteoporosis treatment market estimates and forecast, 2018 - 2030 (USD Million)
Figure 84 South Africa key country dynamics
Figure 85 South Africa Postmenopausal osteoporosis treatment market estimates and forecast, 2018 - 2030 (USD Million)
Figure 86 Saudi Arabia key country dynamics
Figure 87 Saudi Arabia Postmenopausal osteoporosis treatment market estimates and forecast, 2018 - 2030 (USD Million)
Figure 88 UAE key country dynamics
Figure 89 UAE Postmenopausal osteoporosis treatment market estimates and forecast, 2018 - 2030 (USD Million)
Figure 90 Kuwait key country dynamics
Figure 91 Kuwait Postmenopausal osteoporosis treatment market estimates and forecast, 2018 - 2030 (USD Million)
Figure 92 Rest of MEA key country dynamics
Figure 93 Rest of MEA Postmenopausal osteoporosis treatment market estimates and forecast, 2018 - 2030 (USD Million)
Figure 94 Heat map analysis
Figure 95 Market participant categorization
Figure 96 Postmenopausal osteoporosis treatment market share analysis, 2022
Figure 97 Strategy framework

Companies Mentioned

  • Teva Pharmaceuticals Industries Ltd.
  • Pfizer Inc.
  • Merck & Co.
  • Novartis AG
  • Eli Lilly and Company
  • AbbVie (Allergan plc.)
  • F. Hoffmann-La Roche Ltd.
  • Cipla Inc.
  • Amgen Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages180
PublishedMay 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 9.12 Billion
Forecasted Market Value ( USD ) by 2030 $ 13.7 Billion
Compound Annual Growth Rate5.2%
Regions CoveredGlobal
No. of Companies Mentioned9

Related Topics

Related Reports

Global Postmenopausal Osteoporosis Treatment Market - Product Image

Global Postmenopausal Osteoporosis Treatment Market

  • Report
  • 200 Pages
  • Global
From
Postmenopausal Osteoporosis Treatment Global Market Report 2024 - Product Image

Postmenopausal Osteoporosis Treatment Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Postmenopausal Osteoporosis Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Postmenopausal Osteoporosis Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 182 Pages
  • Global
From
Postmenopausal osteoporosis - Pipeline Insight, 2024 - Product Image

Postmenopausal osteoporosis - Pipeline Insight, 2024

  • Drug Pipelines
  • 120 Pages
  • Global
From
Global Osteoporosis Drugs Market by Drug Type (Bisphosphonates, Calcitonin, Parathyroid Hormone Therapy), Route of Administration (Injectable, Oral), Application - Forecast 2024-2030 - Product Image

Global Osteoporosis Drugs Market by Drug Type (Bisphosphonates, Calcitonin, Parathyroid Hormone Therapy), Route of Administration (Injectable, Oral), Application - Forecast 2024-2030

  • Report
  • 181 Pages
  • Global
From

About the Postmenopausal Osteoporosis Treatment Market

Postmenopausal Osteoporosis Treatment is a key component of Women's Health. Osteoporosis is a condition that affects women after menopause, when their bones become weak and brittle due to a decrease in estrogen levels. Treatment for postmenopausal osteoporosis typically involves medications that help to slow down bone loss and increase bone density. These medications can be taken orally or through injections. Additionally, lifestyle changes such as increasing physical activity, eating a balanced diet, and quitting smoking can help to reduce the risk of developing osteoporosis. There are a number of companies that offer treatments for postmenopausal osteoporosis. These include pharmaceutical companies such as Eli Lilly, Merck, and Pfizer, as well as biotechnology companies such as Amgen and Genentech. Additionally, there are a number of generic drug manufacturers that offer generic versions of these medications. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.